Addington v. Texas, 441 U.S. 418 (1979).

Advisory Committee on Evidence Rules. (2000, December). Proposed Amendment: Rule 702.

Ahlbom, A., and Feychting, M. (1993). Studies of Electromagnetic Fields and Cancer: How Inconsistent?Environmental Science and Technology, 27, 1018–1020.Google Scholar

Allen v. Pennsylvania Engineering Corp., 102 F.3d 194 (5th Cir. 1996).

Alonso-Zaldivar, R., and Maharaj, D. (2000, September 21). Tests Show Firestone ‘Had to Know,‘Probers Say: Congress Cites New Evidence Against Tire Maker as Sentiment Swings in Favor of Criminal Penalties in Such Cases. Los Angeles Times, C1.Google Scholar

Ambrosini v. Labarraque, 101 F.3d 129 (D.C. Cir. 1996).

Amdur, M. O., Doull, J., and Klaassen, C. D. (Eds.). (1991). Casarett and Doull's Toxicology (4th ed.). New York: Pergamon Press.Google Scholar

American and Foreign Ins. Co. v. General Elec. Co., 45 F.3d 13f5 (6th Cir. 1995).

American Federation of Labor and Congress of Indus. Organizations v. Occupational Safety and Health Admin., U.S.Dept. of Labor, 965 F.2d 962 (11th Cir. 1992).

American Law Institute. (2005). Restatement of the Law: Torts: Liability for Physical Harm (Proposed Final Draft).

American Petroleum Institute. (2003). Shanghai Studies: Internal Documents (unveiled in litigation), 1–163.

Ames, B. N. (1989). What Are the Major Carcinogens in the Etiology of Human Cancer? Environmental Pollution, Natural Carcinogens, and Causes of Human Cancer: Six Errors. In V. T. Devita, Jr., S. Hellman, and S. A. Rosenberg (Eds.), Important Advances in Oncology (pp. 237–247). Philadelphia: Lippincott.Google Scholar

Amici Curiae of the Lymphona Foundation of America, Carl F. Cranor, Devra Davis, Peter l. Defur, Brian G. Durie, Alan H. Lockwood, David Ozonoff, Arnold J. Schecter, and David Wallinga in Support of Respondents, U.S.Supreme Court, Dow Chemical Co., Monsanto Co., et al. v. Stephenson and Issacson. (2003). [“Agent Orange” Litigation].

Amicus Brief of Professor Alvan R. Feinstein in Support of Respondent at 4–8, Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (1993).

Amicus Brief of Professor Kenneth Rothman, et al. In Support of Petitioners at 3–7, Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (1993).

Amorgianos v. National Railway Passenger Corp., 303 F.3d 256 (2d Cir. 2002).

Anderson, L. M., Ward, J. M., Fox, S. D., Isaaq, H. J., and Riggs, C. W. (1986). Effects of a Single Dose of Polycholorinated Biphenyls to Infant Mice on N-Nitrosodimethylamine-Initiated Lung and Liver Tumors. International Journal of Cancer, 38(1), 109–116.CrossRefGoogle Scholar

Anderson v. Bessemer City, 470 U.S. 564 (1985).

Andrews, L. S., and Snyder, R. (1991). Toxic Effects of Solvents and Vapors. In M. O. Amdur, J. Doull, C. D. Klaassen (Eds.), Casarett and Doull's Toxicology (4th ed., pp. 681–722). New York: Pergamon Press.

Aristotle, . (1985). Nicomachean Ethics (T. Irwin, Trans.). Indianapolis: Hackett.Google Scholar

Ashby, J., and Tennant, R. W. (1988). Chemical Structure, Salmonella Mutagenicity and Extent of Carcinogenicity as Indicators of Genotoxic Carcinogensesis among 222 Chemicals Tested in Rodents by the U.S. NCI/NTP. Mutation Research, 204, 17–115.CrossRefGoogle ScholarPubMed

Baer, K., and Shudtz, M. (2005, May 6). Data Gaps White Paper. Presented at the Ward, Kershaw Environmental Law Symposium: The Data Gaps Dilemma: Why Toxic Ignorance Threatens Public Health sponsored by the University of Maryland School of Law. Washington, DC.Google Scholar

Bailey, L. A., Gordis, L., and Green, M. D. (1994). Reference Guide on Epidemiology. In Reference Manual on Scientific Evidence (1st ed., pp. 121–180). Washington, DC: Federal Judicial Center.Google Scholar

Barefoot v. Estelle, 463 U.S. 880 (1983).

Benedi v. McNeil-P.P.C., Inc., 66 F.3d 1378 (4th Cir. 1995).

Benigni, R., and Giuliani, A. (1999). Tumor Profiles and Carcinogenic Potency in Rodents and Humans: Value for Cancer Risk Assessment. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis and Ecotoxicology Reviews, 17(1), 45–67.CrossRefGoogle Scholar

Berenson, A. (2003, May 18). Trial Lawyers Are Now Focusing on Lawsuits Against Drug Makers. New York Times. Retrieved from http://www.nytimes.com.

Berenson, A. (2005, July 11). First Vioxx Suit: Entryway into a Legal Labyrinth? New York Times. Retrieved from http://www.nytimes.com.

Berenson, A. (2005, August 20). Jury Calls Merck Liable in Death of Man on Vioxx. New York Times. Retrieved from http://www.nytimes.com.

Berenson, A. (2005, August 21). For Merck, Vioxx Paper Trail Won't Go Away. New York Times. Retrieved from http://www.nytimes.com.

Berger, M. A. (1994a). Evidentiary Framework. In Reference Manual on Scientific Evidence (pp. 37–117). Washington, DC: Federal Judicial Center.Google Scholar

Berger, M. A. (1994b). Procedural Paradigms for Applying the Daubert Test. Minnesota Law Review, 78, 1345–1386.Google Scholar

Berger, M. A. (1997). Eliminating General Causation: Notes Towards a New Theory of Justice and Toxic Torts. Columbia Law Review, 97, 2117–2152.CrossRefGoogle Scholar

Berger, M. A. (2000). The Supreme Court's Trilogy on the Admissibility of Expert Testimony. In Reference Manual on Scientific Evidence (2nd ed., pp. 9–38). Washington, DC: Federal Judicial Center.Google Scholar

Berger, M. A. (2001, Summer). Upsetting the Balance between Interests: The Impact of Supreme Court's Trilogy on Expert Testimony in Toxic Tort Litigation. Law and Contemporary Problems, 64, 289–326.CrossRefGoogle Scholar

Berger, M. A. (2005). What Has a Decade of Daubert Wrought?American Journal of Public Health, 95(Suppl. 1), S59–S65.CrossRefGoogle Scholar

Bernstein, D. E. (1994). The Admissibility of Scientific Evidence after Daubert v. Merrell Dow Pharmaceuticals Inc. Cardozo Law Review 15, 2137–2181.Google Scholar

Black, B., and Lilienfeld, D. E. (1984). Epidemiologic Proof in Toxic Tort Litigation. Fordham Law Review, 52, 732–785.Google Scholar

Black v. Food Lion, Inc., 171 F.3d 308 (5th Cir. 1998).

Black v. Food Lion, Case No. 97–11404 (1999).

Black's Law Dictionary. (1968). (4th ed.). St. Paul: West.

Black's Law Dictionary. (2004). (8th ed.). St. Paul: West.

Blanchard v. Eli Lilly and Company, 207 F. Supp. 2d 308 (D. Vt. 2002).

Boguski, M. S. (2002). Comparative Genomics: The Mouse that Roared. Nature, 420, 515–516.CrossRefGoogle ScholarPubMed

Bond, J. A., et al. (1995). Epidemiological and Mechanistic Data Suggest that 1,3-Butadiene Will Not Be Carcinogenic to Humans at Exposures Likely to Be Encountered in the Environment or Workplace. Carcinogenesis, 16, 165–171.CrossRefGoogle ScholarPubMed

Bradley v. Brown, 42 F.3d 434 (7th Cir. 1994).

Brasher v. Sandoz Pharmaceuticals Corp., and Quinn v. Sandoz Pharmaceuticals Corp., 160 F. Supp. 2d 1291 (2001).

Braun v. Lorillard, Inc., 84 F.3d 230 (7th Cir.), cert. denied, 117 S.Ct. 480 (1996).

Breyer, S. S. (2000). Introduction. In Reference Manual on Scientific Evidence (2nd ed., pp. 1–8). Washington, DC: Federal Judicial Center.Google Scholar

Brock v. Merrell Dow Pharmaceuticals, Inc., 884 F.2d 166 (5th Cir. 1989), modified, 884 F.2d 166 (5th Cir. 1989), cert. denied, 494 U.S. 1046 (1990).

Brock v. Merrell Dow Pharmaceuticals, Inc., 874 F.2d 307 (5th Cir. 1989), cert. denied, 494 U.S. 1046 (1990).

Brodeur, P. (1985). Outrageous Misconduct. New York: Pantheon Books.Google Scholar

Brunner, M. J., Sullivan, T. M., Singer, A. W., Ryan, M. J., Toft, R. S., II, Menton, S. W., et al. (1996). An Assessment of the Chronic Toxicity and Oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor-1254 and Aroclor-1260 Administered in Diet to Rats. Columbus, OH: Batelle Study No. SC920192, Chronic Toxicity and Oncogenicity Report.

Bunting v. Jamieson, 984 P.2d 467 (Wyo. 1999).

Calabrese, E. J. (1993, April 13). Did Occupational Exposure to ETO Cause Mr. Walter Allen's Brain Tumor? [Report].

Cancer BACUP, Non-Hodgkin's Lymphoma Information Centre. (2004, June 1). What Are Non-Hodgkin's Lymphomas? Retrieved September 22, 2004 from http://www.cancerbacup.org.uk/Cancertype/Lymphomanon-Hodgkins/General/WhatareNHLs.

Capiello, D. (2005). Oil Industry Funding Study to Contradict Cancer Claims. Houston Chronicle, April 29, 2005, AD: A1.

Capra, D. J. (1998). The Daubert Puzzle. Georgia Law Review, 32, 699–782.Google Scholar

Carbone, M., Klein, G., Gruber, J., and Wong, M. (2004, August 1). Modern Criteria to Establish Human Cancer Etiology. Cancer Research, 64, 5518–5524.CrossRefGoogle ScholarPubMed

The Carcinogenic Potency Project. (n.d.). Summary of Carcinogenic Potency Database by Chemical: Nonhuman Primates and Dogs. Retrieved February 2, 2001 from ftp://potency.berkeley.edu/pub/tables/chemicalsummary.other.text.

Carmichael v. Samyang Tire, Inc., 131 F.3d 1433 (1997).

Carroll v. Litton Sys., Inc., No. B-C-88–253, 1990 WL 312969 (W.D.N.C. Oct.. 29, 1990).

Carruth, R. S., and Goldstein, B. D. (2001). Relative Risk Greater than Two in Proof of Causation in Toxic Tort Litigation. Jurimetrics Journal, 41, 195–209.Google Scholar

Casey v. Ohio Medical Products, Inc., 877 F. Supp. 1380 (N.D. Cal 1995).

Castleman, B. (1981). Regulations Affecting Use of Carcinogens. In N. I. Sax (Ed.), Cancer Causing Chemicals (pp. 78–98). New York: Van Nostrand Reinhold.Google Scholar

Cavallo v. Star Enter., 892 F. Supp. 756 (E.D. Va. 1995).

Cella v. United States, 998 F2d 419 (C.A. 7 (Ind.) 1993).

Chambers v. Exxon Corp., 81 F. Supp. 2d 661 (M.D. La. 2000).

Chan, P. K., and Hayes, A. W. (1989). Principles and Methods for Acute Toxicity and Eye Irritancy. In A. W. Hayes (Ed.), Principles and Methods of Toxicology (2nd ed., pp. 169–220). New York: Raven Press.Google Scholar

Chen, B., Zhao, W.-L., Jin, J., Xue, Y.-Q, Cheng, X., Chen, X.-T., Cui1, J., Chen, Z.-M., Cao, Q., Yang, G., Yao, Y., Xia, H.-L, Tong, J.-H., Li, J.-M.Chen, J., Xiong, S.-M., Shen, Z.-X., Waxman, S., Chen, Z. and Chen, S.-J. (2005). Clinical and Cytogenetic Features of 508 Chinese Patients with Myelodysplastic Syndrome and Comparison with Those in Western Countries. Leukemia 19, 767–775CrossRefGoogle ScholarPubMed

Chen, J., Stampfer, M. J., Hough, H. L., Garcia-Closas, M., Willett, W. C., Hennekens, C. H., et al. (1998). A Prospective Study of N-Acetyltransferase Fenotype, Red Meat Intake, and Risk of Colorectal Cancer. Cancer Research, 58, 3307–3311.Google Scholar

Chengelis, C. P., and Gad, S. C. (1992). Introduction. In C. P. Chengelis and S. C. Gad (Eds.), Animal Models in Toxicology (pp. 1–17). New York: Marcel Dekker.Google Scholar

Christoffel, T., and Teret, S. P. (1991). Epidemiology and the Law: Courts and Confidence Intervals. American Journal of Public Health, 81, 1661–1666.CrossRefGoogle ScholarPubMed

Claar v. Burlington N.R.R., 29 F.3d 499 (9th Cir. 1994).

Clayson, D. B. (2001). Toxicological Carcinogenesis. New York: Lewis.Google Scholar

Clayson, D. B., Krewski, D., and Munro, I. (Eds.). (1985). Toxicological Risk Assessment, Vol. I: Biological and Statistical Criteria. Boca Raton, FL: CRC Press.Google Scholar

Cleary, E. W., et al. (Eds.). (1979). McCormick on Evidence. (2nd ed.). St. Paul: West.Google Scholar

Cleary, E. W., et al. (Eds.). (1984). McCormick on Evidence. (3rd ed.). St. Paul: West.Google Scholar

Clermont, K. M., and Eisenberg, T. (2000). Anti-Plaintiff Bias in the Federal Appellate Courts. Judicature, 84, 128–134.Google Scholar

Coghlan, L. G., Gimenez-Conti, I., Kleiner, H. E., Fischer, S. M., Runhaug, J. E., Conti, C. J., et al. (2000). Development and Initial Characterization of Several New Inbred Strains of SENCAR Mice for Studies of Multistage Skin Carcinogenesis. Carcinogenesis, 21(4), 641–646.CrossRefGoogle ScholarPubMed

Cogliano, V. J., Baan, R. A., Straif, K., Grosse, Y., Secretan, M. B., El Ghissassi, F., and Kleihues, P. (2004). The Science and Practice of Carcinogen Identification and Evaluation. Environmental Health Perspectives, 112, 1269–1274.CrossRefGoogle ScholarPubMed

Cohen, S. M. (2001). Alternative Models for Carcinogenicity Testing: Weight of Evidence Evaluations across Models. Toxicologic Pathology, 29(Suppl.), 183–190.CrossRefGoogle ScholarPubMed

Cohrssen, J. J., and Covello, V. T. (1989). Risk Analysis: A Guide to Principles and Methods for Analyzing Health and Environmental Risks. Washington, DC: White House Council on Environmental Quality.Google Scholar

Collet, J. P., Macdonald, N., Cashman, N., Pless, R., and the Advisory Committee on Causality Assessment. (2000). Monitoring Signals for Vaccine Safety: The Assessment of Individual Adverse Event Reports by an Expert Advisory Committee. Bulletin of the World Health Organization, 78, 178–185.Google ScholarPubMed

Cone, M. (2003, April 20). Cause for Alarm over Chemicals. Los Angeles Times, A1.

Conney, A. H. (1982). Induction of Microsomal Enzymes by Foreign Chemicals and Carcinogenesis by Polycyclic Aromatic Hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Research, 42, 3875–4917.Google Scholar

Cooter and Gell v. Hartmarx Corp., 496 U.S. 384 (1989).

Craighead, J. (Ed.). (1995). Pathology of Environmental and Occupational Disease. St. Louis: Mosby.Google Scholar

Cranor, C. F. (1993). Regulating Toxic Substances. New York: Oxford University Press.CrossRefGoogle Scholar

Cranor, C. F. (1997). Eggshell Skulls and Loss of Hair from Fright: Some Moral and Legal Principles that Protect Susceptible Subpopulations. Environmental Toxicology and Pharmacology, 4, 239–245.CrossRefGoogle ScholarPubMed

Cranor, C. F. (2003, Fall). Daubert and the Acceptability of Legal Decisions. Law and Philosophy Newsletter, 127–131.Google Scholar

Cranor, C. F. (2004). Some Legal Implications of the Precautionary Principle: Improving Information Generation and Legal Protections. European Journal of Oncology, Library Vol. 2, 31–51.Google Scholar

Cranor, C. F. (2005). Scientific Reasoning in the Laboratory and the Law. American Journal of Public Health, 95 (Suppl. 1), S121–S128.CrossRefGoogle Scholar

Cranor, C. F., and Eastmond, D. A. (2001). Scientific Ignorance and Reliable Patterns of Evidence in Toxic Tort Causation: Is There a Need for Liability Reform?Law and Contemporary Problems, 64, 5–48.CrossRefGoogle Scholar

Cranor, C. F., Fischer, J. G., and Eastmond, D. A. (1996). Judicial Boundary-Drawing and the Need for Context-Sensitive Science in Toxic Torts after Daubert v. Merrell Dow Pharmaceuticals, Inc. Virginia Environmental Law Journal, 16, 1–77.Google Scholar

Cranor, C. F., and Strauss, D. (2005). Case Studies in Science and the Law. Article submitted for publication.

Cullen, M. R., Rosenstock, L., and Brooks, S. M. (1995). Clinical Approach and Establishing a Diagnosis of an Environmental Medical Disorder. In S. M. Brooks (Ed.), Environmental Medicine (pp. 217–231). St. Louis: Mosby.Google Scholar

Curfman, C. D., Morrissey, S., and Drazen, J. M. (2005). Expression of Concern: Bombardier, et al., Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis]. New England Journal of Medicine, 343, 2813–2814. Located at www.NEJM.org. December 20, 2005.CrossRefGoogle Scholar

Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (1993).

Daubert v. Merrell Dow Pharm., Inc., 727 F. Supp. 570 (S.D. Cal. 1989), aff'd, 951 F.2d 1128 (9th Cir. 1991), vacated, 509 U.S. 579 (1993).

Daubert v. Merrell Dow Pharm., Inc., 951 F.2d 1128 (9th Cir. 1991), vacated, 509 U.S. 579 (1993).

Daubert v. Merrell Dow Pharm., Inc., 43 F.3d 1311 (9th Cir. 1995), on remand from 509 U.S. 579 (1993).

Dawson, B., and Berenson, A. (2005, August 20). Working Through a Decision Cut in Shades of Deep Gray. New York Times. Retrieved from http://www.nytimes.com.

Deitz, C. C., Zheng, W., Leff, M. A., Gross, M., Wen, W. Q., Doll, M. A., et al. (2000). N-Acetyltransferase-2 Genetic Polymorphism, Well-Done Meat Intake, and Breast Cancer Risk among Postmenopausal Women. Cancer Epidemiology Biomarkers and Prevention, 9, 905–910.Google ScholarPubMed

Denemark, H. (1987). Improving Litigation Against Drug Manufacturers for Failure to Warn Against Possible Side Effects: Keeping Dubious Lawsuits from Driving Good Drugs Off the Market. Case Western Reserve Law Review, 40, 413–428.Google Scholar

Denninson, Richard. (2005, May 6). U.S. HPVChallenge and Beyond. Presented at the Ward, Kershaw Environmental Law Symposium: The Data Gaps Dilemma: Why Toxic Ignorance Threatens Public Health sponsored by the University of Maryland School of Law. Washington, DC.Google Scholar

Development in the Law – Confronting the New Challenges of Scientific Evidence. (1995). Harvard Law Review, 108, 1481–1605.CrossRef

Dixon, L., and Gill, B. (2002). Changes in the Standards for Admitting Expert Evidence in Federal Cases Since the Daubert Decision.Santa Monica, CA: RAND Institute for Civil Justice.Google Scholar

Dixon, R. (1986). Toxic Responses of the Reproductive System. In C. D. Klaassen, M. O. Amdur, and J. Doull (Eds.), Casarett and Doull's Toxicology (3rd ed., pp. 432–477). New York: Macmillan.Google Scholar

Donaldson v. Central Illinois Public Service Company, 199 Ill. 2d 63 (2002).

Dow Chemical Company, Monsanto Company v. Stephenson, and Isaacson (Supreme Court of the United States, 2002).

Ealy v. Richardson-Merrell, Inc., 897 F.2d 159 (D.C. Cir.), cert. denied, 498 U.S. 950 (1990).

Eco, U. (1983). The Name of the Rose. New York: Harcourt Brace Jovanovich.Google Scholar

Editorial: For Honest Reports of Drug Trials. (2004, September 11). New York Times, A14.

Edmond, G., and Mercer, D. (1996). Recognizing Daubert: What Judges Should Know About Falsificationism. Expert Evidence, 5, 28–40.Google Scholar

Egilman, D. S., and Rankin Bohme, S. (Eds.). (2005). Corporate Corruption of Science [Special Issue]. International Journal of Occupational and Environmental Health, II(4), available at http://www.ijoel.com

EPA, EDF, CMA Agree on Testing Program Targeting 2,800 Chemicals. (1998, October). Environmental Health Newsletter, 37, 193.

Epstein, S. S. (1990). Corporate Crime: Why We Cannot Trust Industry-Derived Safety Studies. International Journal of Health Services, 20, 433–455.CrossRefGoogle ScholarPubMed

European Environmental Agency. (2000). Late Lessons from Early Warnings: The Precautionary Principle 1896–2000. Copenhagen, Denmark: European Environmental Community.

Eysenck, H. J. (1991). Were We Really Wrong?American Journal of Public Health, 133, 429–432.Google ScholarPubMed

Faigman, D. L., Kaye, D. H., Saks, M. J., and Sanders, J. (2002). Modern Scientific Evidence: The Law and Science of Expert Testimony. St. Paul: West.Google Scholar

Falk, H., Creech, J. L., Jr., Heath, C. W., Jr., Johnson, M. N., and Key, M. M. (1974, October 7). Hepatic Disease among Workers at a Vinyl Chloride Polymerization Plant. Journal of the American Medical Association, 230, 59–68.CrossRefGoogle Scholar

Faustman, E. M., and Omenn, G. S. (2001). Risk Assessment. In C. D. Klaassen (Ed.), Casarett and Doull's Toxicology (6th ed., pp. 83–104). New York: McGraw-Hill.Google Scholar

Federal Judicial Center. (Ed.). (2000). Reference Manual on Scientific Evidence (2nd ed.). Washington, DC: Federal Judicial Center.

Federal Judicial Center. (Ed.). (2004). Manual for Complex Litigation (4th ed.). Washington, DC: Federal Judicial Center.

Feldman v. Lederle Labs., 479 A.2d 374 (N.J. 1984).

Fenichel, G. M., Lane, D. A., Livengood, J. R., Horwitz, S. J., Menkes, J. H., and Schwarrtz, J. F. (1989). Adverse Events Following Immunization: Assessing Probability of Causation. Pediatric Neurology, 5, 287–290.CrossRefGoogle ScholarPubMed

Ferebee v. Chevron Chemical, Inc., 736 F.2d 1529 (D.C. Cir. 1984).

Finley, L. M. (1999). Guarding the Gate to the Courthouse: How Trial Judges are Using Their Evidentiary Screening Role to Remake Tort Causation Rules. DePaul Law Review, 49, 335–375.Google Scholar

Fisk, M. C. (1999, November 10). Chicago Hope: A $28M Verdict. National Law Journal, A10.

Fiss, O. M. (1984). Against Settlement. Yale Law Journal, 93, 1073–1090.CrossRefGoogle Scholar

Fleiss, J. L. (1986). Significance Tests Have a Role in Epidemiologic Research: Reactions to A.M. Walker. American Journal of Public Health, 76, 559–560.CrossRefGoogle Scholar

Foster, K. R., and Huber, P. W. (1997). Judging Science: Scientific Knowledge and the Federal Court. Cambridge, MA: MIT Press.Google Scholar

Fox, and Goldsworthy, . (1993). Molecular Analysis of the H-ras Gene: An Understanding of Mouse Liver Tumor Development. CIIT Activities, 13(7), 1–6.Google Scholar

Freiman, J. A., Chalmers, T. C., Smith, H., et al. (1978). The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial: Survey of 71 ‘Negative’ Trials. New England Journal of Medicine, 299, 690–694.CrossRefGoogle ScholarPubMed

Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., and Skipper, H. E. (1990). Quantitative Comparison of Toxicity of Anticancer Agents in Mouse, Rat, Hamster, Dog, Monkey and Man. Cancer Chemotherapy Reports, 50, 199–244.Google Scholar

Friedman, L. C., Daynard, R. A., and Banthin, C. N. (2005). How Tobacco-Friendly Science Escapes Scrutiny in the Courtroom. American Journal of Public Health, 95(Suppl. 1), S16–S19.CrossRefGoogle ScholarPubMed

Frye v. U.S., 293 F.2d 1013 (D.C. Cir. 1923).

Fung, V. A., et al. (1995). The Carcinogenesis Bioassay in Perspective: Application in Identifying Human Cancer Hazards. Environmental Health Perspectives, 103, 680–683.CrossRefGoogle ScholarPubMed

Furst, A. (1990). Yes, But Is It a Human Carcinogen?Journal of the American College of Toxicology, 9, 1–18.CrossRefGoogle Scholar

Furuya, I., and Watanabe, S. (1993). Discriminative Stimulus Properties of Ephedra Herb (Ephedra sinica) in Rats. Yakubutsu Seishin Kodo, 13, 33–38.Google ScholarPubMed

Gad, S. C. (1992). Model Selection and Scaling. In C. P. Chengelis and S. C. Gad (Eds.), Animal Models in Toxicology (pp. 813–839). New York: Marcel Dekker.

Gallo, M. A. (2001). History and Scope of Toxicology. In C. D. Klaassen (Ed.), Casarett and Doull's Toxicology (6th ed., pp. 3–10). New York: McGraw-Hill.Google Scholar

Garlinger v. Hardee's Food Systems, Inc., 16 Fed. Appx 232 2001 929767 (4th Cir. 2001).

General Electric Company v. Joiner, 113 S.Ct. 512 (1997).

General Electric Company v. Joiner, 522 U.S. 136 (1997).

Gerrard, M. (Ed.). (1999). The Law of Environmental Justice: Theories and Procedures to Address Disproportionate Risks. Chicago: Section of Environment, Energy, and Resources, The American Bar Association.

Gillette, C. P., and Krier, J. E. (1999). Risk, Courts and Agencies. University of Pennsylvania Law Review, 38, 1077–1109.Google Scholar

Gitlin, J. N., Cook, L. L., Linton, O. W., Garrett-Mayer, E. (2004). Comparison of “B” Readers' Interpretations of Chest Radiographs for Asbestos Related Changes. Academic Radiology, 11, 843–856.CrossRefGoogle ScholarPubMed

Glaser v. Thompson Med. Co., 32 F.3d 969 (6th Cir. 1994).

Glastetter v. Novartis Pharmaceuticals Corp., 252 F.3d 986 (8th Cir. 2001).

Globetti v. Sandoz Pharmaceuticals, Corp., 111 F. Supp. 2d 1174 (N.D. Ala. 2000).

Gold, L., et al. (1989). Interspecies Extrapolation in Carcinogenesis: Prediction between Rats and Mice. Environmental Health Perspectives, 81, 211–219.CrossRefGoogle ScholarPubMed

Goldman, A. I. (1999). Knowledge in a Social World. New York: Oxford University Press.CrossRefGoogle Scholar

Goldstein, B. D., and Henifin, M. S. (2000). Reference Guide on Toxicology. In Federal Judicial Center (Ed.), Reference Manual on Scientific Evidence (2nd ed., pp. 401–438). Washington, DC: Federal Judicial Center.Google Scholar

Goodman, S. N., and Royall, R. (1988). Evidence and Scientific Research. American Journal of Public Health, 78, 1568–1574.CrossRefGoogle ScholarPubMed

Goodstein, D. (2000). How Science Works. In Federal Judicial Center (Ed.), Reference Manual on Scientific Evidence (2nd ed., pp. 67–82). Washington, DC: Federal Judicial Center.Google Scholar

Gordon, A. E., and Shaughnessy, A. F. (2003). Saw Palmetto for Prostate Disorders. American Family Physician, 67, 1281–1283.Google ScholarPubMed

Gottesman, M. H. (1998). From Barefoot to Daubert to Joiner: Triple Play or Double Error. Arizona Law Review, 40, 753–780.Google Scholar

Gottesman, M. H. (2003, February 27). Paper presented at Science, the Courts, and Protective Justice sponsored by the Science and Environmental Health Network and Georgetown Environmental Law and Policy Institute. Washington, DC

Goyer, R. A., and Clarkson, T. W. (2001). Toxic Effects of Metals. In C. D. Klaassen (Ed.), Casarett and Doull's Toxicology (6th ed., pp. 818–821). New York: McGraw-Hill.Google Scholar

Graham, M. H. (2000). The Expert Witness Predicament: Determining ‘Reliable’ under the Gatekeeping Test of Daubert, Kumho and Proposed Amended Rule 702 of the Federal Rules of Evidence. Miami Law Review, 54, 317–357.Google Scholar

Graham v. Playtex Prod., Inc., 993 F. Supp. 127 (N.D.N.Y. 1998).

Gray, George M., Li, P., Shlykhter, I., and Wilson, R. (1995). An Empirical Examination of Factors Influencing Prediction of Carcinogenic Hazard across Species. Regulatory Toxicology and Pharmacology, 22, 283–291.CrossRefGoogle ScholarPubMed

Green, M. D. (1992). Legal Theory: Expert Witnesses and Sufficiency of Evidence in Toxic Substances Litigation. Northwestern University Law Review, 86, 643–699.Google Scholar

Green, M. D. (1996). Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation. Philadelphia: University of Pennsylvania Press.CrossRefGoogle Scholar

Green, M. D. (1999). The Road Less Well Traveled (and Seen): Contemporary Lawmaking in Products Liability. DePaul Law Review, 49, 377–403.Google Scholar

Greene, G. (1999). The Woman Who Knew Too Much: Alice Stewart and the Secrets of Radiation.Ann Arbor: University of Michigan Press.CrossRefGoogle Scholar

Greenland, S. (Ed.). (1987). Evolution of Epidemiologic Ideas: Annotated Readings on Concepts and Methods.Newton Lower Falls, MA: Epidemiology Resources.Google Scholar

Greenland, S. (1991). Invited Commentary: Science Versus Public Health Actions: Those Who Were Wrong Are Still Wrong. American Journal of Public Health, 133, 435–436.Google Scholar

Greenland, S. (1999). Relation of Probability of Causation to Relative Risk and Doubling Dose: A Methodologic Error That Has Become a Social Problem. American Journal of Public Health, 89, 1166–1169.CrossRefGoogle ScholarPubMed

Greenland, S., and Robins, J. M. (1988). Conceptual Problems in the Definition and Interpretation of Attributable Fractions. American Journal of Epidemiology, 128, 1185–1196.CrossRefGoogle ScholarPubMed

Greenland, S., and Robins, J. M. (2000). Epidemiology, Justice, and the Probability of Causation. Jurimetrics Journal, 40, 321–340.Google Scholar

Gregus, Z., and Klaassen, C. D. (2001). Mechanisms of Toxicity. In C. D. Klaassen (Ed.), Casarett and Doull's Toxicology (6th ed., pp. 35–82). New York: McGraw-Hill.Google Scholar

Gross, S. R. (1991). Expert Evidence. Wisconsin Law Review, 1991, 1113–1232.Google Scholar

Gulf South Insulation v. Consumer Product Safety Commission, 701 F.2d 1137 (5th Cir. 1983).

Haack, S. (1999). An Epistemologist in the Bramble-Bush: At the Supreme Court with Mr. Joiner. Journal of Health Politics, Policy and Law, 26, 217–237.CrossRefGoogle Scholar

Haack, S. (2005). Trial and Error: The Supreme Court's Philosophy of Science. American Journal of Public Health, 95(Suppl. 1), S66–S74.CrossRefGoogle ScholarPubMed

Haar, J. (1995). A Civil Action. New York: Random House, Inc.Google Scholar

Hagen v. Richardson-Merrell, 697 F. Supp. 334 (N.D. Ill. 1988).

Hagerty v. LandL Marine Services, Inc, 788 F.2d 315 (1986).

Halpern, A. C., and Altman, J. F. (1999). Genetic Predisposition to Skin Cancer. Current Opinion in Oncology, 11, 132–138.CrossRefGoogle ScholarPubMed

Harman, G. (1994). The Inference to the Best Explanation. Philosophical Review, 74, 89–90.Google Scholar

Hartzema, A. G., Porta, M., and Tilson, H. H. (Eds.). (1998). Pharmacoepidemiology: An Introduction (3rd ed.). Cincinnati, OH: Harvey Whitney Books.Google Scholar

Hattis, D. (1997). Variability in Susceptibility: How Big, How Often, For What Responses to What Agents?Environmental Toxicology and Pharmacology, 4, 195–208.CrossRefGoogle ScholarPubMed

Hattis, D., Banati, P., and Goble, R. (1999, December). Distributions of Individual Susceptibility among Humans for Toxic Effects – For What Fraction of Which Kinds of Chemicals and Effects Does the Traditional 10-Fold Factor Provide How Much Protection?Annals of the New York Academy of Sciences, 895, 286–316.CrossRefGoogle Scholar

Hattis, D., and Barlow, K. (1996). Human Interindividual Variability in Cancer Risks. Technical and Management Challenges. Health and Ecological Risk Assessment, 2, 194–220.CrossRefGoogle Scholar

Heath, C. W., Jr., Falk, H., and Creech, L., Jr. (1975). Characteristics of Cases of Angiosarcoma of the Liver among Vinyl Chloride Workers in the United States. Annals of the New York Academy of Sciences, 231–248.CrossRefGoogle ScholarPubMed

Heikkila, R. E., et al. (1984). Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice. Science, 224, 1451–1453.CrossRefGoogle ScholarPubMed

Heller v. Shaw Industries, 167 F.3d 146 (3d Cir. 1999).

Hileman, B. (1994). Findings Point to Complexity of Health Effects of Electric, Magnetic Fields. Chemical Engineering News, 72, 27.Google Scholar

Hill, A. B. (1987). The Environment and Disease: Association or Causation? In S. Greenland (Ed.), Evolution of Epidemiologic Ideas: Annotated Readings on Concepts and Methods (pp. 15–20). Newton Lower Falls, MA: Epidemiology Resources. (Reprinted from Proceedings of the Royal Society of Medicine, 1965, 58, 295–300.)Google Scholar

Hilts, P. J. (2003). Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation. New York: Alfred K. Knopf.Google Scholar

Hines v. Consolidated Rail Corp., 926 F.2d 262 (3d Cir. 1991).

Holbrook v. Lykes, 80 F.3d 777 (1996).

Hollingworth, J. G., and Lasker, E. G. (2004, Winter). The Case Against Differential Diagnosis: Daubert, Medical Causation Testimony and the Scientific Method. Journal of Health Law, 37(1), 85–112.Google Scholar

Honoré, T. (1995). The Morality of Tort Law – Questions and Answers. In D. G. Owen (Ed.), Philosophical Foundations of Tort Law (pp. 73–95). Oxford: Clarendon Press.Google Scholar

Hooper, K., and McDonald, T. A. (2000). The PBDE's: An Emerging Environmental Challenge and Another Reason for Breast-Milk Monitoring Programs. Environmental Health Perspectives, 108(5), 387–392.CrossRefGoogle Scholar

Hooper, L. L., Cecil, J. S., and Willging, T. E. (2001). Assessing Causation in Breast Implant Litigation: The Role of Science Panels. Law and Contemporary Problems, 64(4), 139–189.CrossRefGoogle Scholar

Hopkins v. Dow Corning Corp., 33 F.3d 1116 (9th Cir. 1994).

Howerton v. Arai Helmet, Ltd., 348 N.C. 440, 697 S.E.2d 674 (2004).

Huber, P. (1991). Galileo's Revenge: Junk Science in the Courtroom. New York: Basic Books.Google Scholar

Huff, J. (1992). Applicability to Humans of Rodent-Specific Sites of Chemical Carcinogenicity: Tumors of the Forestomach and of the Harderian, Preputial, and Zymbal Glands Induced by Benzene. Journal of Occupational Medicine and Toxicology, 1, 109–141.Google Scholar

Huff, J. (1993). Chemicals and Cancer in Humans: First Evidence in Experimental Animals. Environmental Health Perspectives, 100, 201–210.CrossRefGoogle ScholarPubMed

Huff, J. (1996, December). Alpha-2u-Globulin Nephropathy, Posed Mechanisms, and White Ravens. Environmental Health Perspectives, 104, 1264–1267.CrossRefGoogle Scholar

Huff, J. (1999). Long-term Chemical Carcinogenesis Bioassays Predict Human Cancer Hazard: Issues, Controversies and Uncertainties. Annals of the New York Academy of Sciences, 895, 56–79.CrossRefGoogle Scholar

Huff, J., and Hoel, D. (1992). Perspective and Overview of the Concepts and Value of Hazard Identification as the Initial Phase of Risk Assessment for Cancer and Human Health. Scandinavian Journal of Work Environment and Health, 18, 83–89.Google ScholarPubMed

Huff, J., and Melnick, R. (2002, October 23–24). Chemical Carcinogenesis Bioassays: Critical for the Sensible Application of the Precautionary Principle for Protecting Public Health. Presentation to the Collegium Ramazzini. Bologna, Italy.Google Scholar

Huff, J., and Rall, D. P. (1992). Relevance to Humans of Carcinogenesis Results from Laboratory Animal Toxicology Studies. In J. M. Last and R. B. Wallace (Eds.), Maxcy-Rosenau-Last Public Health and Preventive Medicine (13th ed., pp. 433–452). Norwalk, CT: Appleton and Lange.Google Scholar

Hutchinson, T. A., and Lane, D. A. (1989). Standardized Methods of Causality Assessment of Suspected Adverse Drug Reactions. Journal of Clinical Epidemiology, 42, 5–16.CrossRefGoogle Scholar

Hyland, K. (1997). Hedging in Scientific Research Articles. Amsterdam: John Benjamins.Google Scholar

In re: Agent Orange product liability litigation, 611 F. Supp. 1223 (E.D.N.Y. 1985).

In re: Bendectin Prod. Liab. Litig., 732 F. Supp. 744 (E.D. Mich. 1990).

In re: Breast Implant Litigation, 11 F. Supp. 2d 1217 (2000).

In re: Ephedra Products Liability Litigation, 393 F. Supp. 2d 181 (2005).

In re: Hanford Nuclear Reservation Litigation 292 F.3d 1124 (C.A.9 (Wash. 2002)).

In re: Joint E. and S. Dist. Asbestos Litig., 827 F. Supp. 1014 (S.D.N.Y. 1993).

In re: Joint E. and S. Dist. Asbestos Litig., 758 F. Supp. 199 (S.D.N.Y. 1991), aff'd, 52 F.3d 1124 (2d Cir. 1995).

In re: MeridiaProds. Liab. Litig., 328 F. Supp. 2d 791 (N.D. Ohio 2004).

In re: Paoli R.R. Yard PCBLitig., 706 F. Supp. 358 (E.D. Pa. 1988), rev'd, 916 F.2d 829 (3d Cir. 1990), cert. denied, 499 U.S. 961 (1991).

In re: Paoli R.R. Yard PCBLitigation, 916 F.2d 829 (3d Cir. 1990).

In re: Paoli R.R. Yard PCBLitigation, 35 F.3d 717 (3d Cir. 1994), cert. denied, 115 S.Ct. 1253 (1995).

In re: Phenylpropanolamine (PPA) Products Liability Litigation, 289 F. Supp. 2d 1230 (2003)(W.D. Washington).

In re: Redlands Tort Litigation (2001), referenced in Lockheed Martin Co. v. Superior Court, 109 Cal. App.4th 24 (2003).

In re: TMILitigation, 193 F.3d 613 (3d Cir. 1999).

In re: Winship, 397 U.S. 358 (1970).

Infante, P. F. (1992). Benzene and Leukemia: The 0.1 ppm ACGIH Proposed Threshold Limit Value for Benzene. Applied Occupational Environmental Hygiene, 7, 253–262.CrossRefGoogle Scholar

Infante, P. F. (1995, May-August). Benzene and Leukemia: Cell Types, Latency and Amount of Exposure Associated with Leukemia. Advances in Occupational Medicine and Rehabilitation, Q(2), 107–120.Google Scholar

Institute of Medicine. (1994). Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. (A. G. Hartzema, M. Porta, and H. H. Tilson, Eds.). Washington, DC: National Academy Press.

Institute of Medicine and National Research Council, Committee on the Framework for Evaluating the Safety of Dietary Supplements. (2005). Dietary Supplements: A Framework for Evaluating Safety. Washington, DC: National Academy Press.

Institute of Medicine, Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides. (1996). Veterans and Agent Orange. Washington DC: National Academy Press.

International Agency for Research on Cancer (IARC). (n.d.). Lists of IARC Evaluations. Monograph Series. Revised July 22, 2004. Retrieved from http://www-cie.iarc.fr/monoeval/grlist.html.

International Agency for Research on Cancer (IARC). (n.d.). Overall Evaluations of Carcinogenicity to Humans, Group 1: Carcinogenic to Humans. Monograph Series. Revised July 7, 2004. Retrieved from http://www-cie.iarc.fr/Monoeval/crthgr01.html.

International Agency for Research on Cancer (IARC). (n.d.). Overall Evaluations of Carcinogenicity to Humans, Group 2A: Probably Carcinogenic to Humans. Monograph Series. Revised July 7, 2004. Retrieved from http://www-cie.iarc.fr/monoeval/crthgr02a.html.

International Agency for Research on Cancer (IARC). (n.d.). Preamble. Monograph Series. Revised August 18, 2004. Retrieved from http://www-cie.iarc.fr/monoeval/preamble.html.

International Agency for Research on Cancer (IARC). (n.d.). Preamble, Section 8: Studies of Cancer in Humans. Monograph Series. Revised December 17, 1998. Retrieved from http://www-cie.iarc.fr/monoeval/studieshumans.html.

International Agency for Research on Cancer (IARC). (n.d.). Preamble, Section 9: Studies of Cancer in Experimental Animals. Monograph Series. Revised January 5, 1999. Retrieved from http://www-cie.iarc.fr/monoeval/studiesanimals.html.

International Agency for Research on Cancer (IARC). (n.d.). Preamble, Section 12: Evaluation. Monograph Series. Revised January 5, 1999. Retrieved from http://www-cie.iarc.fr/monoeval/eval.html.

International Agency for Research on Cancer (IARC). (n.d.). Preamble, Section 2: Objective and Scope. Monograph Series. Revised December 7, 1999. Retrieved from http://www-cie.iarc.fr/monoeval/objectives.html.

International Agency for Research on Cancer (IARC). (1974). Benzene. Monograph Series, 7, 203. Revised March 19, 1998. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol07/benzene.html.

International Agency for Research on Cancer (IARC). (1976). Safrole, Isosafrole, and Dihydrosafrole. Monograph Series, 10, 231. Revised March 22, 1998. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol10/safrole.html.

International Agency for Research on Cancer (IARC). (1982a). Benzene. Monograph Series, 29, 93. Revised April 9, 1998. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol29/benzene.html.

International Agency for Research on Cancer (IARC). (1982b). Benzidine and Its Sulphate, Hydrochloride and Dihydrochloride. Monograph Series, 29, 149. Revised April 9, 1998. Retrieved from http://wwwcie.iarc.fr/htdocs/monographs/vol29/benzidine.html.

International Agency for Research on Cancer (IARC). (1987a). Benzene (Group 1). Monograph Series, Supplement 7, 120. Revised February 6, 1998. Retrieved from http://www.cie.iarc.fr/htdocs/monographs/suppl7/benzene.html.

International Agency for Research on Cancer (IARC). (1987b). Benzidine-Based Dyes (Group 2A). Monograph Series, Supplement 7, 125. Revised February 11, 1998. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/suppl17/benzidinedyes.html.

International Agency for Research on Cancer (IARC). (1987c). Chloroethyl Nitrosoureas. Monograph Series, Supplement 7, 150. Revised February 6, 1998. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/suppl7/chloroethylnitrosoureas.html.

International Agency for Research on Cancer (IARC). (1987d). Polychlorinated Biphenyls. Monograph Series, Supplement 7, 322. Revised February 11, 1998. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/suppl7/polychlorinatedbiphenyls.html.

International Agency for Research on Cancer (IARC). (1987e). Vinyl Chloride (Group 1). Monograph Series, Supplement 7, 373. Revised February 10, 1998. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/suppl7/vinylchloride.html.

International Agency for Research on Cancer (IARC). (1993). Occupational Exposures of Hairdressers and Barbers and Personal Use of Hair Colourants; Some Hair Dyes, Cosmetic Colourants, Industrial Dyestuffs and Aromatic Amines.” Monograph Series, 57, n.p. Revised August 22, 1997. Retrieved from http://www-cie.iarc.fr/htdocs/indexes/vol57index.html.

International Agency for Research on Cancer (IARC). (1994). Ethylene Oxide (Group 1). Monograph Series, 60, 73. Revised August 26, 1997. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol60/m60-02.htm.

International Agency for Research on Cancer (IARC). (1995a). Formaldehyde (Group 2A). Monograph Series, 62, 217. Revised August 13, 1997. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol62/formal.html.

International Agency for Research on Cancer (IARC). (1995b). Tetrachloroethylene. Monograph Series, 63, 159. Revised May 20, 1997. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol63/tetrachloroethylene.htm.

International Agency for Research on Cancer (IARC). (1995c). Trichloroethylene. Monograph Series, 63, 75. Revised May 20, 1997. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol63/trichloroethylene.htm.

International Agency for Research on Cancer (IARC). (1997). Polychlorinated Dibenzo-para-Dioxins. Monograph Series, 69, 33. Revised August 12, 1997. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol69/dioxin.html.

International Agency for Research on Cancer (IARC). (1999a). Consensus Report: The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation.” IARC Scientific Publications No. 146 (D. B. McGregor, J. M. Rice, and S. Venitt, Eds.). Rev. April 29, 1999. Retrieved from http://www-cie.iarc.fr/htdocs/iarcpubs/pub146/pub146consensus.html.

International Agency for Research on Cancer (IARC). (1999b). 1,3-Butadiene (Group 2A). Monograph Series, 71, 109. Revised April 12, 1999. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol71/002-butadiene.html.

International Agency for Research on Cancer (IARC). (2000). Neutrons. Monograph Series, 75, n.p. Revised April 19, 2000. Retrieved from http://www-cie.iarc.fr/htdocs/monographs/vol75/neutrons.html.

James, F., Jr., and Hazard, G. C., Jr. (1977). Civil Procedure (2nd ed.). Boston: Little, Brown and Company.Google Scholar

James, R. C. (1985). General Principles of Toxicology. In P. L. Williams and J. L. Burson (Eds.), Industrial Toxicology: Safety and Health Applications in the Workplace (pp. 7–26). New York: Lifetime Learning Publications.Google Scholar

Jasanoff, S. (1995). Science at the Bar: Law, Science and Technology in America. Cambridge, MA: Harvard University Press.Google Scholar

Jasanoff, S. (2005). Law's Knowledge: Science for Justice in Legal Settings. American Journal of Public Health, 95(Suppl. 1), S49–S58.CrossRefGoogle ScholarPubMed

Joiner v. General Electric Co., 864 F. Supp. 1310 (N. D. Georgia 1994).

Joiner v. General Electric Co., 78 F.3d 524 (11th Cir. 1996).

Joyce, C. (1990, April 14). Public Being ‘Misled’ over Asbestos Dangers: Science Magazine Publishes Paper Claiming Public Health Risk. New Scientist, 16.

Kalaria, R. N., Mitchell, M. J., and Harik, S. L. (1987). Correlation of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity with Blood-Brain Barrier Monoamine Oxidase Activity. Proceedings Natl. Acad. Sci. U.S.A., 84(10), 3521–3525.CrossRefGoogle ScholarPubMed

Kannankeril v. Terminix International Inc., 128 F.3d 802 (3d Cir. 1997).

Kassirer, J. P. (1989). Diagnostic Reasoning. Annals of Internal Medicine, 110, 893–900.CrossRefGoogle ScholarPubMed

Kassirer, J. P., and Cecil, J. S. (2002, September 13). Inconsistency in Evidentiary Standards for Medical Testimony: Disorder in the Courts. Journal of the American Medical Association, 28(11), 1382–1387.CrossRefGoogle Scholar

Kassirer, J. P., and Kopelman, R. I. (1991). Learning Clinical Reasoning.Baltimore: Williams and Wilkins.Google Scholar

Keeton, W. P., Dobbs, D. B., Keeton, R. E., and Owen, D. G. (1984). Prosser and Keeton on Torts (5th ed.). St. Paul, MN: West.Google Scholar

Kelsey, K. T., and LaMontagne, A. D. (1992, October 13). Plaintiff's Expert Opinion Affidavit [Letter].

Kennedy, D. (2004, July). Science, Law and the IBM Case. Science, 305(16), 309.CrossRefGoogle ScholarPubMed

Kennedy v. Collagen Corp., 974 F.2d 1342 (9th Cir. 1992).

Kimbrough, R. D. (1982). Pathological Changes in Human Beings Acutely Poisoned by Dimethylnitrosamine. In P. N. Magee (Ed.), Nitrosamines and Human Cancer (pp. 25–34). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.Google Scholar

Kimbrough, R. D. (1985). Case Studies. In P. L. Williams and J. L. Burson (Eds.), Industrial Toxicology: Safety and Health Applications in the Workplace (pp. 414–431). New York: Lifetime Learning Publications.Google Scholar

Kitcher, P. (1993). The Advancement of Science: Science without Legend, Objectivity without Illusions.New York: Oxford University Press.Google Scholar

Klaassen, C. D. (Ed.). (2001). Casarett and Doull's Toxicology (6th ed.). New York: McGraw-Hill.Google Scholar

Klaassen, C. D., Amdur, M. O., and Doull, J. (Eds.). (1996). Casarett and Doull's Toxicology (5th ed.). New York: McGraw-Hill.Google Scholar

Klatskin, G., and Kimberg, D. V. (1969). Recurrent Hepatitis Attributable to Halothane Sensitization in an Anesthetist. The New England Journal of Medicine, 280, 515–522.CrossRefGoogle Scholar

Kogevinas, M., and Boffetta, P. (1991). Letter to the editor. British Journal of Industrial Medicine, 48, 575–576.Google Scholar

Kolata, G. (2000, September 26). Controversial Drug Makes a Comeback. New York Times, F1.

Kramer, M. S., and Lane, D. A. (1992). Causal Propositions in Clinical Research and Practice. Journal of Clinical Epidemiology, 45, 639–649.CrossRefGoogle ScholarPubMed

Kuhn, T. S. (1977). The Essential Tension. Chicago: University of Chicago Press.Google Scholar

Kumho Tire Co. v. Carmichael, 526 U.S. 137 (1999).

Lake, C. R., and Quirk, R. S. (1984). CNS Stimulants and the Look-Alike Drugs. Psychiatry Cin. North American, 7, 689–701.Google ScholarPubMed

Lakie v. Smithkline Beecham, 965 F. Supp. 49 (D.D.C. 1997).

Lan, Q., et al. (2004). Hematoxtoxicity in Workers Exposed to Low Levels of Benzene. Science, 306, 1774–1776.CrossRefGoogle ScholarPubMed

Lilienfeld, D. E. (1991). The Silence: The Asbestos Industry and Early Occupational Cancer Research – A Case Study. American Journal of Public Health, 81, 791–798.CrossRefGoogle ScholarPubMed

Lockheed Martin Co. v. Superior Court, 109 Cal. App.4th 24 (2003).

Logerquist v. McVey, 196 Ariz. 470, 1 P.3d 113 (2000).

Lynch v. Merrell-National Lab., Div. of Richardson-Merrell, Inc., 830 F.2d 1190 (1st Cir. 1987).

MacMahon, B., and Pugh, T. F. (1987). Causes and Entities of Disease. In S. Greenland (Ed.), Evolution of Epidemiologic Ideas: Annotated Readings on Concepts and Methods (pp. 26–34). Newton Lower Falls, MA: Epidemiology Resources. (Reprinted from Methods of Preventive Medicine, pp. 11–18, by D. W. Clark and B. MacMahon, Eds., 1967, Boston: Little, Brown and Company)Google Scholar

Magistrini v. One Hour Martinizing, 180 F. Supp. 2d 584 (2002).

Maguire, J. M. (1947). Evidence, Common Sense and Common Law. Chicago: Foundation Press.Google Scholar

Manson, J., and Wise, L. D. (1991). Teratogens. In M. O. Amdur, C. D. Klaassen, and J. Doull (Eds.), Casarett and Doull's Toxicology (4th ed., pp. 226–254). New York: Pergamon Press.Google Scholar

Marder v. G.D. Searle and Co., 630 F. Supp. 1087 (D. Md. 1986).

Markowitz, G., and Rosner, D. (2002). Deceit and Denial: The Deadly Politics of Industrial Pollution. Berkeley: University of California Press.Google Scholar

Marx, J. (1990). Animal Carcinogen Testing Challenged. Science, 250, 743.CrossRefGoogle ScholarPubMed

Mattison, D. R., and Craighead, J. E. (1995). Reproductive System. In J. E. Craighead (Ed.), Pathology of Environmental and Occupational Disease (pp. 559–572). St. Louis: Mosby.Google Scholar

Maurer v. United States, 668 F.2d 98 (2d Cir. 1981).

McClain, R. M., Keller, D., Casciano, D., Fu, P., MacDonald, J., Popp, J., et al. (2001). Neonatal Mouse Model: Review of Methods and Results. Toxicologic Pathology, 29 (Suppl.), 128–137.CrossRefGoogle ScholarPubMed

McClain v. Metabolife International, Inc., 2005 WL 477861 (11th Cir. (Ala)).

McCullock v. H. B. Fuller Co., 61 F.3d 1038 (2d Cir. 1995).

McElveen, J. C., and Amantea, C. (1995). Risk Symposium: Legislating Risk Assessment. University of Cincinnati Law Review, 63, 1553–1598.Google Scholar

McGarity, T. O. (1997). Some Throughts on the ‘Deossifying’ the Rule-Making Process. Duke Law Journal 41, 1335–1462.Google Scholar

McGarity, T. O. (2005). Daubert and the Proper Role for the Courts in Health, Safety, and Environmental Regulation. American Journal of Public Health, 95(Suppl. 1), S92–S98.CrossRefGoogle ScholarPubMed

McGarity, T. O. and Shapiro, S. A. (1993). Workers at Risk: The Failed Promise of the Occupational Safety and Health Administration. Westport, CT: Praeger.Google Scholar

McKee v. Moore, 648 P.2d 21 (Okla. 1982).

Meier, B. (2004, September 8). Medical Editors Likely to Call for Registration of Drug Tests at Outset. New York Times. Retrieved from http://www.nytimes.com.

Melnick, R. L., and Kohn, M. C. (1995). Mechanistic Data Indicate that 1, 3-Butadiene Is a Human Carcinogen. Carcinogenesis, 16, 157–163.CrossRefGoogle ScholarPubMed

Melnick, R. L., Kohn, M. C., and Huff, J. (1997, September). Weight of Evidence Versus Weight of Speculation to Evaluate the Alpha2u-Globulin Hypothesis. Environmental Health Perspectives, 105, 904–906.CrossRefGoogle ScholarPubMed

Mendes-Silva v. United States, 980 F.2d 1482 (D.C. Cir. 1993).

Merrell Dow Pharmaceuticals, Inc. v. Havner, 953 S.W.2d 706 (1997).

Merrill, R. (2004). FDA Regulatory Requirements as Tort Standards. Journal of Law and Policy, Science for Judges II: The Practice of Epidemiology and Administrative Agency Created Science, 12, 549–558.Google Scholar

Metabolife International v. Wornick, 264 F.3d 832 (9th Cir. 2001).

Metzger, R. (3 June 2005). The Demise of Daubert in State Courts. Commentary for LexisNexis MEALEY'S Emerging Toxic Torts, 14(5). Available from http://www.mealeys.com.

Michaels, D. (1988). Waiting for the Body Count: Corporate Decision Making and Bladder Cancer in the U.S. Dye Industry. Medical Anthropology Quarterly, 2, 215–227.CrossRefGoogle Scholar

Michaels, D. (Ed.). (2005). Scientific Evidence and Public Policy [Special issue]. American Journal of Public Health, 95 (Suppl. 1).CrossRef

Michaels, D. (2005, June). Doubt Is Their Product. Scientific American, 96, 96–101.CrossRefGoogle Scholar

Michaels, D., and Monforton, C. (2005). Manufacturing Uncertainty: Contested Science and the Protection of the Public's Health and Environment. American Journal of Public Health, 95(Suppl. 1), S39–S48.CrossRefGoogle ScholarPubMed

Micklethwait, J., and Wooldridge, A. (2004). The Right Nation: Conservative Power in America. New York: Penguin Press.Google Scholar

Mill, J. S. (1941). A System of Logic: Ratiocinative and Inductive. London: Longmany, Green and Company.Google Scholar

Mitchell v. Gencorp Inc.,165 F.3d 778 (10th Cir. 1999).

Moore v. Ashland Chemical Inc., 151 F.3d 269 (5th Cir. (Tex.) 1998).

Mossman, B. T., et al. (1990). Asbestos: Scientific Developments and Implications for Public Policy. Science, 247, 294–301.CrossRefGoogle ScholarPubMed

The Mouse Genome Sequencing Consortium, MacAndrew, A. (2002, December 5). Comparison of Mouse and Human Coding Genes. Nature, 420, 520–562.

The Mouse Genome Sequencing Consortium, Waterston, R., et al. (2002, December 5). Initial Sequencing and Comparative Analysis of the Mouse Genome. Nature, 420, 520–562.CrossRef

National Institute of Environmental Health Sciences of the National Institutes of Health. (1998). Assessment of Health Effects from Exposure to Power-line Frequency Electric and Magnetic Field. (C. J. Portier and M. S. Wolfe, Eds.). Research Triangle Park, NC: NIH Publication No. 98–3981.

National Research Council. (1983). Risk Assessment in the Federal Government: Managing the Process. Washington, DC: U.S. Government Printing Office.

National Research Council. (1984). Toxicity Testing: Strategies to Determine Needs and Priorities. Washington, DC: U.S. Government Printing Office.

National Research Council. (1999). Arsenic in Drinking Water. Washington, DC: National Academy Press. Also at http://www.nap.edu/books/0309076293/html/

Nesson, C. (1985). The Evidence or the Event? On Judicial Proof and the Acceptability of Verdicts. Harvard Law Review, 98, 1357–1392.CrossRefGoogle Scholar

Neutra, R. R., DelPizzo, V., and Lee, G. M. (2002). An Evaluation of the Possible Risks from Electric and Magnetic Fields (EMFs) from Power Lines, Internal Wiring, Electrical Occupations, and Appliances. Oakland: California Department of Health Services.Google Scholar

Nicholson, W. J. (1988). IARC Evaluations in the Light of Limitations of Human Epidemiologic Data. Annals of the New York Academy of Sciences, 534, 44–54.CrossRefGoogle ScholarPubMed

Occupational Safety and Health Act of 1970. 29 U.S.C.§ 655(b)(5) (1976).

Occupational Safety and Health Administration (OSHA). Occupational Exposure to Benzene; Proposed Rule and Notice Hearing. 50 Fed. Reg. 50512 (Dec. 10, 1985) (to be codified at 29 C.F.R. pt. 1910).

Oddi v. Ford Motor Co., 234 F.3d 143 (3d Cir. 2000).

O'Leary v. Secretary of HHS, No. 90–1729V, 1997 WL 254217.

Ominsky v. Chas. Weinhagen and Co. (1911), 129 N.W. Rptr. 845–846.

Ong, E. K., and Glantz, S. A. (2000, April 8). Tobacco Industry Efforts Subverting International Agency for Research on Cancer's Second-Hand Smoke Study. Lancet, 355, 1253–1259.CrossRefGoogle ScholarPubMed

Oppel, R. A., Jr. (2000, September 22). Environmental Tests ‘Falsified,’ U.S. Says. New York Times, A14.

Ozonoff, D. (2005). Epistemology in the Courtroom: A Little ‘Knowledge’ Is a Dangerous Thing. American Journal of Public Health, 95(Suppl. 1), S13–S15.CrossRefGoogle ScholarPubMed

Ozonoff, D., and Boden, L. I. (1987). Truth and Consequences: Health Agency Responses to Environmental Health Problems. Science Technology and Human Values, 12, 70–77.Google Scholar

Page, T. (1978). A Generic View of Toxic Chemicals and Similar Risks. Ecology Law Quarterly, 7, 207–244.Google Scholar

Palca, J. (1992). Lead Researcher Confronts Accusers in Public Hearing. Science, 256, 437–438.CrossRefGoogle ScholarPubMed

Paoli RR. Yard PCB Litigation, 35 F.3d 717 (1994).

Parkinson, A. (2001). Biotransformation of Xenobiotics. In C. D. Klaassen (Ed.), Casarett and Doull's Toxicology (6th ed., pp. 133–224). New York: McGraw-Hill.Google Scholar

Peer Review Committee to Review Perchlorate. (2004, June). Perchlorate in Drinking Water: A Science and Policy Review. Irvine: University of California, Irvine.

Peer Review of Defendants' Expert's Report by Anonymous Reviewer. (2004, January 12).

Peer Review of Plaintiffs' Expert's Report by Anonymous Reviewer. (2004, January 12).

Peer Review of Plaintiffs' Expert's Report by Anonymous Reviewer. (2004, April 14).

People v. O'Neill, Film Recovery Systems, et al., 550 N.E. 2d 1090 (1990).

Perera, F. (1996). Molecular Epidemiology: Insights into Cancer Susceptibility, Risk Assessment, and Prevention. Journal of the National Cancer Institute, 88, 496–509.CrossRefGoogle Scholar

Perera, F. P., Boffetta, P., and Nisbet, I. C. T. (1989). What Are The Major Carcinogens in the Etiology of Human Cancer? Industrial Carcinogens. In V. T. Devita, Jr., S. Hellman, and S. A. Rosenberg (Eds.), Important Advances in Oncology (pp. 249–265). Philadelphia: Lippincott.Google Scholar

Petersen, M. (2000, August 29). Settlement Is Approved in Diet Drug Case. New York Times, C2.

Pitot, H. C., III, and Dragan, Y. P. (2001). Chemical Carcinogensesis. In C. D. Klaassen (Ed.), Casarett and Doull's Toxicology. (6th ed., pp. 241–320). New York: McGraw-Hill.Google Scholar

Poirier, M. C. (2001). In Memoriam: James A. Miller (1915–2000). Carcinogenesis, 22(4), 681–683.CrossRef

Poole, C. (1987). Beyond the Confidence Interval. American Journal of Public Health, 77, 195–199.CrossRefGoogle ScholarPubMed

Preston, R. J., and Hoffmann, G. R. (2001). Genetic Toxicology. In C. D. Klaassen (Ed.), Casarett and Doull's Toxicology (6th ed., pp. 321–350). New York: McGraw-Hill.Google Scholar

Quine, W. V. O. (1960). Word and Object. Cambridge, MA: MIT Press.Google Scholar

Rall, D. P., Hogan, M. D., Huff, J. E., Schwetz, B. A., and Tennant, R. W. (1987). Alternatives to Using Human Experience in Assessing Health Risks. Annual Review of Public Health, 8, 355–385.CrossRefGoogle ScholarPubMed

Raloff, J. (1995). Physicists Offer Reassurances on EMF: Electromagnetic Fields and Their Link to Cancer Might Be Tenuous. Science News, 47, 308.CrossRefGoogle Scholar

Rawls, J. (1971). A Theory of Justice. Cambridge, MA: Belknap Press of Harvard University Press.Google Scholar

Rawls, J. (1993). Political Liberalism. Cambridge, MA: Harvard University Press.Google Scholar

Renaud v. Martin Marietta Corp., 749 F. Supp. 1545 (D. Colo. 1990).

Rice, J. M. (1999). Editorial: On the Application of Data on Mode of Action to Carcinogenesis. Toxicological Sciences, 49, 175–177.Google Scholar

Rice, J. M., et al. (1999). Rodent Tumors of Urinary Bladder, Renal Cortex, and Thyroid Gland. Toxicological Sciences, 49, 166.CrossRefGoogle ScholarPubMed

Richardson v. Richardson-Merrell, Inc., 857 F.2d 823 (D.C. Cir. 1988), cert. denied, 493 U.S. 882 (1989).

Rinsky, R. A., Hornung, R. W., Silver, S. R., and Tseng, C. Y. (2002). Benzene Exposure and Hematopoietic Mortality: A Long-Term Epidemiological Risk Assessment. American Journal of Industrial Medicine, 42, 474–480.CrossRefGoogle Scholar

Roberti v. Andy's Termite and Pest Control, Inc., 6 Cal. Rptr. 3d 827 (2003).

Robins, J. M., and Greenland, S. (1989a). Estimability and Estimation of Excess and Etiologic Fractions. Statistics in Medicine, 8, 845–859.CrossRefGoogle Scholar

Robins, J. M., and Greenland, S. (1989b). The Probability of Causation under a Stochastic Model for Individual Risk. Biometrics, 46, 1125–1138.CrossRefGoogle Scholar

Robins, J. M., and Greenland, S. (1991). Estimability and Estimation of Expected Years of Life Lost Due to a Hazardous Exposure. Statistics in Medicine, 10, 79–93.CrossRefGoogle ScholarPubMed

Rosen v. Ciba-Geigy Corp., 78 F.3d 316 (7th Cir.), cert. denied, 519 U.S. 819 (1996).

Rothman, K. (1986). Modern Epidemiology. Boston: Little, Brown and Company.Google Scholar

Rothman, K. J. (1987). Causes. In S. Greenland (Ed.), Evolution of Epidemiologic Ideas: Annotated Readings on Concepts and Methods (pp. 40–45). Chestnut Hill, MA: Epidemiology Resources.Google Scholar

Rothman, K. J., and Greenland, S. (2005). Causation and Causal Inference in Epidemiology. American Journal of Public Health, 95 (Suppl. 1), S144–S150.CrossRefGoogle ScholarPubMed

Roueché, B. (1982, May/June). The Lemonade Mystery. The Saturday Evening Post, 59, 120.Google Scholar

Ruden, C. (2001). Interpretations of Primary Carcinogenicity Data in 29 Trichloroethylene Risk Assessments. Toxicology, 169, 209–225.CrossRefGoogle ScholarPubMed

Saakbo Rubanick v. Witco Chem. Corp., 242 N.J. Super. 36, 576 A.2d 4 (1990).

Safety: Congress Cites New Evidence Against Tire Maker as Sentiment Swings in Favor of Criminal Penalties in Such Cases (2000, September 21). Los Angeles Times, C1.

Saks, M. J. (1992). Do We Really Know Anything About the Behavior of the Tort Litigation System – And Why Not?Pennsylvania Law Review, 140, 1147–1289.CrossRefGoogle Scholar

Saks, M. J. (2000). The Aftermath of Daubert: An Evolving Jurisprudence of Expert Evidence. Jurimetrics Journal, 40, 229–241.Google Scholar

Sanders, J. (1994). Scientific Validity, Admissibility and Mass Torts after Daubert. Minnesota Law Review, 38, 1387–1441.Google Scholar

Sanders, J. (2001). Bendectin on Trial: A Study of Mass Tort Litigation. Ann Arbor: University of Michigan Press.

Sanders, J., and Machal-Faulks, J. (2001). The Admissibility of Differential Diagnosis Testimony to Prove Causation in Toxic Tort Cases: The Interplay of Adjective and Substantive Law. Law and Contemporary Problems, 64, 107–138.CrossRefGoogle Scholar

Santone, K. S., and Powis, G. (1991). Mechanism of and Tests for Injuries. In W. J. Hayes, Jr. and E. R. Laws, Jr. (Eds.), Handbook of Pesticide Toxicology (pp. 169–214). New York: Harcourt Brace Jovanovich.Google Scholar

Santosky v. Kramer, 455 U.S. 745 (1982).

Savitz, D. A. (1993). Health Effects of Low-Frequency Electric and Magnetic Fields, Special Report Commentary. Environmental Science and Technology, 27, 52–54.CrossRefGoogle Scholar

Savitz, D. A. (2001, September 31). Report to Court Concerning Federal Rule of Evidence 706.

Savitz, D. A., and Andrews, K. W. (1996). Risk of Myelogenous Leukaemia and Multiple Myeloma in Workers Exposed to Benzene. Occupational and Environmental Medicine, 33, 357–358.Google Scholar

Savitz, D. A., and Andrews, K. W. (1997). Review of Epidemiological Evidence on Benzene and Lymphatic and Hematopoietic Cancers. American Journal of Industrial Medicine, 31, 287–295.3.0.CO;2-V>CrossRefGoogle ScholarPubMed

Schlesselman, J. J. (1974). Sample Size Requirements in Cohort and Case-Control Studies of Disease. American Journal of Epidemiology, 99, 381–384.CrossRefGoogle Scholar

Schottenfeld, D., and Haas, J. F. (1979). Carcinogens in the Workplace. CA – Cancer Journal for Clinicians, 29, 144–159.CrossRefGoogle ScholarPubMed

Schuck, P. (1992). Legal Complexity: Some Causes, Consequences, and Cures. Duke Law Journal, 42, 1–52.CrossRefGoogle Scholar

Schuck, P. H. (1993). Multi-Culturalism Redux: Science, Law, and Politics. Yale Law and Policy Review, 11, 1–46.Google Scholar

Shank, R. C., and Herron, D. C. (1982). Methylation of Human Liver DNA after Probable Dimethylnitrosamine Poisoning. In P. N. Magee (Ed.), Nitrosamines and Human Cancer (pp. 153–159). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.

Sheehan v. Daily Racing Form, Inc., 104 F.3d 940 (7th Cir. 1997).

Silbergeld, E. K. (1991). The Role of Toxicology in Causation: A Scientific Perspective. Courts, Health Science and the Law, 1(3), 374–385.Google Scholar

Silver, S. R., Rinsky, R. A., Cooper, S. P., Hornung, R. W., and Lai, D. (2002). Effect of Follow-up Time on Risk Estimates: Longitudinal Examination of the Relative Risks of Leukemia and Multiple Myeloma in a Rubber Hydrochloride Cohort. American Journal of Industrial Medicine, 42, 481–489.CrossRefGoogle Scholar

Sindell v. Abbott Laboratories et al., 26 Cal.3d 588, 607 P.2d 924 (1980).

Skill v. Martinez, 91 F.R.D. 498 (D.N.J. 1981), aff'd on other grounds, 677 F.2d 368 (3d Cir. 1982).

Skyrms, B. (1966). Choice and Chance: An Introduction to Inductive Logic. Belmont, CA: Dickenson.Google Scholar

Smith, M. A., Rubenstein, L., and Ungerleider, R. S. (1994). Therapy-Related Acute Myeloid Leukemia Following Treatment with Epipodophyllotoxins: Estimating the Risks. Medical and Podiatric Oncology, 23, 86–98.CrossRefGoogle ScholarPubMed

Snyder, R. (1984). The Benzene Problem in Perspective. Fundamental and Applied Toxicology, 4, 692–699.CrossRefGoogle Scholar

Snyder v. Secretary of Health and Human Services, 2002 WL 31965742 (Fed. CI 2002).

Soldo v. Sandoz Pharmaceuticals Corporation, Civil Action No. 98–1712 (January 16, 2002).

Soldo v. Sandoz Pharmaceuticals Corp., 244 F. Supp. 2d 434 (W.D. Pa., January 13, 2003).

Soldo v. Sandoz Pharmaceuticals Corporation, 2003 WL 355931 (W.D. Pa.).

Speiser v. Randall, 357 U.S. 513 (1958).

Steenland, K., Bertazzi, P., Baccarelli, A., and Kogevinas, M. (2004). Dioxin Revisited: Developments Since the 1997 IARC Classification of Dioxin as a Human Carcinogen. Environmental Health Perspectives 112(13), 1265–1268.CrossRefGoogle ScholarPubMed

Stephenson v. Dow Chemical Co., 273 F.3d 249 C.A.2 (N.Y.), 2001.

Stevens v. the Secretary of Health and Human Services, 2001 WL 387418 (Fed. CI).

Strong, J. W., et al. (1992). McCormick on Evidence (4th ed.). St. Paul, MN: West.Google Scholar

Sullivan, A. K. (1993). Classification, Pathogenesis, and Etiology of Neoplastic Diseases of the Hematopoietic System. In G. R. Lee, et al. (Eds.), Wintrobe's Clinical Hematology(Vol. 2, 9th ed., pp. 1725–1791). Philadelphia: Lea and Febiger.

Susser, M. (1987). Judgment and Causal Inferences Criteria in Epidemiologic Studies. In S. Greenland (Ed.), Evolution of Epidemiologic Ideas: Annotated Readings on Concepts and Methods (pp. 69–83). Newton Lower Falls, MA: Epidemiology Resources. (Reprinted from American Journal of Epidemiology, 1977, 105, 1–15)Google Scholar

Swift, M., Morrell, D., Massey, R. B., and Chase, C. L. (1991). Incidence of Cancer in 161 Families Affected by Ataxia-telangiectasia. New England Journal of Medicine, 325, 1831–1836.CrossRefGoogle ScholarPubMed

Tanner v. Westbrook, 174 F.3d 542 (5th Cir. 1999).

Temple, R. (1979). Meta-Analysis and Epidemiologic Studies in Drug Development and Postmarketing Surveillance. Journal of the American Medical Association, 281, 841–844.CrossRefGoogle Scholar

Thagard, P. (1999). How Scientists Explain Disease. Princeton: Princeton University Press.Google Scholar

Thomas v. Hoffman-La-Roche, Inc., 731 F. Supp. 224 (N.D. Miss. 1989), aff'd on other grounds, 949 F.2d 806 (5th Cir. 1992).

Thompson, W. D. (1987). Statistical Criteria in the Interpretation of Epidemiologic Data. American Journal of Public Health, 77, 191–194.CrossRefGoogle ScholarPubMed

Thornton, J. (2001). Pandora's Poison: Chlorine, Health and a New Environmental Strategy.Cambridge, MA: MIT Press.Google Scholar

Timbrell, J. (2000). Principles of Biochemical Toxicology (3rd ed.). London: Taylor and Francis.Google Scholar

Tizon, T. A. (2005, May 16). Cases Against Nuclear Plant Finally Heard: After 15 Years of Delays, 2300 Plaintiffs Who Say Radioactive Releases at the Hanford Site Made Them Seriously Ill Wait for a Jury's Decision. Los Angeles Times, A2.

Tomatis, L., Huff, J., Hertz-Picciotto, I., Sandler, D. P., Bucher, J., Boffetta, P., et al. (1997). Avoided and Avoidable Risks of Cancer. Carcinogenesis, 18, 97–105.CrossRefGoogle Scholar

Toole v. Richardson-Merrell, Inc., 251 Cal. App. 2d 689 (1967).

Travis, C. C. (1993). Interspecies Extrapolation of Toxic Data. In R. G. M. Wang, J. B. Knaak, and H. I. Maibach (Eds.), Health Risk Assessment: Dermal and Inhalation Exposure and Absorption of Toxicants (pp. 387–410). Boca Raton, FL: CRC Press.Google Scholar

Travis, C. C., and Hester, S. T. (1991). Global Chemical Pollution. Environmental Science and Technology, 25, 814–819.CrossRefGoogle Scholar

Turpin v. Merrell Dow Pharm., Inc., 959 F.2d 1349 (6th Cir. 1992).

United States. (2000). Federal Rules of Evidence. Washington, DC: U.S. Government Printing Office.

U.S. Congress, Office of Technology Assessment. (1983). The Information Content of Premanufacture Notices. Washington, DC: U.S. Government Printing Office.

U.S. Congress, Office of Technology Assessment. (1987). Identifying and Regulating Carcinogens. Washington, DC: U.S. Government Printing Office.

U.S. Congress, Office of Technology Assessment. (1995). Screening and Testing Chemicals in Commerce. Washington, DC: U.S. Government Printing Office.

U.S. Department of Health and Human Services. (1995). Toxicological Profile for Asbestos.

U.S. Department of Health and Human Services, Food and Drug Administration. Notice on Opportunity for a Hearing on a Proposal to Withdraw Approval of the Indication of Bromocriptine Mesylate (Parlodel) for the Prevention of Physiological Lactation. 59 Fed. Reg. 43347 (Aug. 23, 1994).

U.S. Department of Health and Human Services, National Toxicology Program. (n.d.). Report on Carcinogens. Retrieved June 1, 1999 from http://ntp.niehs.nih.gov/ntpweb/index.cfm?objectid=72016262-BDB7-CEBA-FA60E922B18C2540.

U.S. Department of Health and Human Services, National Toxicology Program (1996, September 26). Listing Criteria. Retrieved May 28, 1999 from http://ntp.niehs.nih.gov/ntpweb/index.cfm?objectid=03C9CE38-E5CD-EE56-D21B94351DBC8FC3.

U.S. Department of Health and Human Services, National Toxicology Program. (2000, October 20). Ninth Annual Report on Carcinogens. Retrieved from http://ehis.niehs.nih.gov/roc/ninth/known.pdf.

U.S. Department of Health and Human Services, National Toxicology Program. (2002a). Safrole: Cas. No. 94–59–7. Tenth Report on Carcinogens.

U.S. Department of Health and Human Services, National Toxicology Program. (2002b). Polychlorinated Biphenyls (PCBs): Cas. No. 1336–36–3. Tenth Report on Carcinogens.

U.S. Department of Health and Human Services, National Toxicology Program. (2005). Benzidine and Dyes Metabolized to Benzidine. In Eleventh Annual Report on Carcinogens. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Retrieved from http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/s020benz.pdf.

U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program. (1996, February). Comparative Initiation/Promotion Skin Pain Studies of B6C3F1 Mice, Swiss (CD-1) Mice, and SENCAR Mice. Technical Report Series, No. 441.

U.S. Department of Health and Human Services, Taskforce on Health Risk Assessment. (1986). Determining Risks to Health: Federal Policy and Practice. Dover, MA: Auburn House.

U.S. Environmental Protection Agency. Perchlorate. Retrieved from http://www.epa.gov/swerffrr/documents/perchlorate.htm.

U.S. Environmental Protection Agency. Proposed Guidelines for Carcinogen Risk Assessment. 61 Fed. Reg. 17960 (April 23, 1996).

U.S. Environmental Protection Agency. (1996, September). PCBs: Cancer Dose-Response Assessment and Application to Environmental Mixtures. Washington, DC: EPA/600/P-96/001F.

U.S. Environmental Protection Agency. (2005, February 23). Arsenic in Drinking Water. Retrieved from http://www.epa.gov/safewater/arsenic.html.

U.S. Food and Drug Administration. Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk. 69 Fed. Reg. 6787 (Feb. 11, 2004).

U.S. Supreme Court. (2003). Federal Rules of Civil Procedure. Retrieved from the Legal Information Institute (Cornell University Law School) at http://www.law.cornell.edu/rules/frcp/.

United States v. Dorsey, 45 F.3d 809 (4th Cir. 1995).

United States v. 14.38 Acres of Land Situated in Leflore County, Mississippi, 80 F.3d 1074 (5th Cir. 1996).

Raalte, H. G. S., and Grasso, P. (1982). Hematological, Myelotoxic, Clastogenic, Carcinogenic, and Leukemogenic Effects of Benzene. Regulatory Toxicology and Pharmacology, 2, 153–176.CrossRefGoogle ScholarPubMed

Venitt, S. (1994). Mechanisms of Carcinogenesis and Individual Susceptibility to 40 Cancers. Clinical Chemistry, 40, 1421–1425.Google Scholar

Vidmar, N. (2005). Expert Evidence, the Adversary System, and the Jury. American Journal of Public Health, Supplement 1, 95, S137–143.CrossRefGoogle ScholarPubMed

Villari v. Terminix Int. Inc., 692 F. Supp. 568 (E.D. Pa. 1988).

Viterbo v. Down Chemical Co., 826 F.2d 420 (5th Cir. 1987).

Waalkes, M. P., et al. (1994). The Scientific Fallacy of Route Specificity of Carcinogenesis with Particular Reference to Cadmium. Regulatory Toxicology and Pharmacology, 20, 119–121.CrossRefGoogle ScholarPubMed

Wade-Greaux v. Whitehall Lab., Inc., 874 F. Supp. 1441 (D.V.I.), aff'd, 46 F.3d 1120 (3d Cir. 1994).

Wade-Greaux v. Whitehall Lab., Inc., 46 F.3d 1120 (3d Cir. 1994).

Wagner, W., and Steinzor, R. (Eds.). (2006). Rescuing Science from Politics. New York: Cambridge University Press.CrossRef

Wald, M. L. (2000, January 29). U.S. Acknowledges Radiation Killed Weapons Workers. New York Times, A1.

Walker, A. M. (1986). Reporting the Results of Epidemiologic Studies. American Journal of Public Health, 76, 556–558.CrossRefGoogle ScholarPubMed

Walker, V. R. (1996). Preponderance, Probability and Warranted Fact Finding. Brooklyn Law Review, 62, 1075–1136.Google Scholar

Walker, V. R. (2006). Transforming Science into Law: Transparency and Default Reasoning in International Trade Disputes. In W. Wagner and R. Steinzor (Eds.), Rescuing Science from Politics. New York: Cambridge University Press.

Ward, E., Smith, A. B., and Halperin, W. (1987). 4,4′-Methylenebis (2-Chloraniline): An Unregulated Carcinogen. American Journal of Industrial Medicine, 12, 537–549.CrossRefGoogle Scholar

Weed, D. (1997). Underdetermination and Incommensurability in Contemporary Epidemiology. Kennedy Institute of Ethics Journal, 7, 107–114.CrossRefGoogle ScholarPubMed

Wells v. Ortho Pharmaceutical Corp., 615 F. Supp. 262 (N.D. Ga. 1985).

Wells v. Ortho Pharm. Corp., 788 F.2d 741 (11th Cir. 1986).

Westberry v. Gislaved Gummi AB, 178 F.3d 257 (4th Cir. 1999).

Willman, D. (2000, June 4). The Rise and Fall of the Killer Drug Rezulin; People Were Dying as Specialists Waged War Against Their FDA Superiors. Los Angeles Times, A1.

Willman, D. (2001, March 11). Risk Was Known as FDA Ok'd Fatal Drug. Los Angeles Times, A1.

Willman, D. (2002, June 30). Hidden Risks, Lethal Truth. Los Angeles Times, 1. Retrieved from http://www.latimes.com.

Witschi, H., and Last, J. (2001). Toxic Regulation of the Respiratory System. In C. D. Klaassen (Ed.), Casarett and Doull's Toxicology (6th ed., pp. 515–534). New York: McGraw-Hill.Google Scholar

Wong, O. (1990). A Cohort Mortality Study and a Case Control Study of Workers Potentially Exposed to Styrene in Reinforced Plastics and Composite Industry. British Journal of Industrial Medicine, 47, 753–762.Google Scholar

Woodward, J., and Goodstein, D. (1996). Conduct, Misconduct and the Structure of Science. American Scientist, 84, 479–490.Google Scholar

World Health Organization. (1994). Brominated Diphenyl Ethers, IPCSEnvironmental Health Criteria 163. Geneva: Author.

Wright, L. (1989). Practical Reasoning. New York: Harcourt Brace Jovanovich.Google Scholar

Wright, L. (2001). Critical Thinking: An Introduction to Analytical Reading and Reasoning.New York: Oxford University Press.

Wright and Miller Treatise, 29 Fed. Prac. and Proc. Evid. §6266.

Wright v. Willamette Industries, Inc., 91 F.3d 1105 (8th Cir. 1996).

Written Direct Testimony of Sander Greenland, Dr. P.H., in Opposition to Baxter Healthcare Corporation's Petition for Declaratory Judgment. (1999, April 30).

Zuchowicz v. United States, 140 F.3d 381 (2d Cir. 1998).